JW Pharmaceutical

Seoul, South Korea Founded: 1945 • Age: 81 yrs Listed
Pharmaceutical products and medical devices are developed and manufactured.

About JW Pharmaceutical

JW Pharmaceutical is a publicly listed company based in Seoul (South Korea) founded in 1945. Pharmaceutical products and medical devices are developed and manufactured. The company has 1,110 employees. JW Pharmaceutical has completed 1 acquisition, including Euvipharm. Its website jw-pharma.co.kr draws about 83 thousand monthly visits. JW Pharmaceutical offers products and services including ν™”μ½œ and νƒ€λ°œλ¦¬μŠ€μ •. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is JWμ€‘μ™Έμ œμ•½.

Company details

JW Pharmaceutical was founded in 1945 and is headquartered in Seoul, South Korea. Operations are focused on the pharmaceutical and medical device sectors, where research and development are conducted alongside manufacturing and distribution of medications and equipment. The full product lifecycle is managed, from initial research to market delivery. Collaborations and partnerships are pursued to expand the product portfolio, with emphasis placed on technological advancements in ongoing initiatives.

  • Headquarters Seoul, South Korea
  • Employees 1,110
  • Stage Public
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Website jw-pharma.co.kr/pharma/ko/main.jsp
  • Social LinkedIn
  • Legal Name Jw Pharmaceutical Corporation
Key Metrics
  • Annual Revenue
    $536.84 M (USD)
    7.77
    as on Dec 31, 2025
  • Net Profit
    $40.36 M (USD)
    -5.5
    as on Dec 31, 2025
  • EBITDA
    $73.83 M (USD)
    4.7
    as on Dec 31, 2025
  • Employee Count
    1,110
  • Investments & Acquisitions

Products & Services of JW Pharmaceutical

JW Pharmaceutical offers a comprehensive portfolio of products and services, including 화콜 and 타발리스정.

화콜
Over-the-counter Drugs

A cold medicine is provided for symptom relief in common ailments.

타발리스정
Prescription Drugs

A treatment for immune thrombocytopenia is offered to manage blood disorders.

People of JW Pharmaceutical

3 people are tracked at JW Pharmaceutical (3 in leadership); the tracked headcount is 1,110.

NameRoleGroup
Kyung-Ha Lee
Chairman and Co-Chief Executive OfficerLeadership
Seiho Chin
Chief Of API Research Center, 센터장Leadership
Meekyung Bae
Chief Of Marketing Strategy OfficeLeadership
Premium access

Complete people profiles for JW Pharmaceutical

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of JW Pharmaceutical

JW Pharmaceutical is a publicly listed company on the KRX with ticker symbol 001060 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date14 Jun 1976
  • Listed onKRX: 1060
  • Listed entityJW Pharmaceutical Corporation
  • Exchange sectorHealth technology
  • ISINKR7001060003
  • Share price24,950.00 KRW (-1.77% on the day) · 2026-10-14
  • Market capitalisation579,876,119,393.00 KRW
  • Price to earnings6.0
  • EPS (diluted, trailing year)4,159.68 KRW
  • Dividend yield2.56%
  • Volume (last session)33,513

Financials of JW Pharmaceutical

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025775.30B KRW58.29B KRW106.62B KRW
2024719.38B KRW61.68B KRW101.83B KRW
2023748.53B KRW35.10B KRW119.21B KRW
2022684.35B KRW30.31B KRW77.33B KRW
2021606.58B KRW-919.2M KRW46.97B KRW
Premium access

Detailed financial statements for JW Pharmaceutical

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by JW Pharmaceutical

JW Pharmaceutical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Euvipharm.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Pharmaceutical ingredients and formulations are manufactured under contract.
euvipharm.com.vnLong An, Vietnam2005Sep 2019β€’β€’β€’β€’
Premium access

Complete acquisition details for JW Pharmaceutical

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of JW Pharmaceutical

3 dated milestones of JW Pharmaceutical across 74 years, from founding to its latest funding, stage changes and deals.

  1. Founded JW Pharmaceutical is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires Euvipharm.

Web traffic of JW Pharmaceutical

The website of JW Pharmaceutical (jw-pharma.co.kr) receives about 83.5K visits a month and ranks #347,046 among all websites worldwide, #292 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    83.5K

    ▲ 3.6% vs previous month

  • Unique visitors
    22.5K

    per month

  • Global rank
    #347,046

    among all websites

  • Category rank
    #292

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with JW Pharmaceutical. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
jwpmall.co.kr
jwpmall.co.kr
100%
#331,475–
kddf.org
100%
32.9K#926,246View details
kimsonline.co.kr
kimsonline.co.kr
79%
#214,400–
jw-lifescience.co.kr
76%
5K#3,788,374View details
health.kr
74%
#14,868View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 29 similar websites and full traffic analytics for JW Pharmaceutical

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 29 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Jw Pharmaceutical

Premium access

Complete news archive for JW Pharmaceutical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about JW Pharmaceutical

JW Pharmaceutical was founded in 1945.

JW Pharmaceutical is headquartered in Seoul, South Korea.

JW Pharmaceutical has 1,110 employees.

Annual revenue of JW Pharmaceutical is $536.84M as on Dec 31, 2025.

JW Pharmaceutical was founded in 1945 and is headquartered in Seoul, South Korea. Operations are focused on the pharmaceutical and medical device sectors, where research and development are conducted alongside manufacturing and distribution of medications and equipment. The full product lifecycle is managed, from initial research to market delivery. Collaborations and partnerships are pursued to expand the product portfolio, with emphasis placed on technological advancements in ongoing initiatives.

JW Pharmaceutical offers ν™”μ½œ and νƒ€λ°œλ¦¬μŠ€μ •.

Yes, JW Pharmaceutical is publicly traded on KRX under the ticker symbol 001060.

JW Pharmaceutical has made 1 acquisition, including Euvipharm.

JW Pharmaceutical operates through Jwμ€‘μ™Έμ œμ•½.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available